Studies & Articles

The following studies show the most recent research related to the use of ibogaine and 5-MeO-DMT for the treatment of addiction, anxiety, depression and PTSD. Dr. Martin Polanco has been collaborating in various studies related to the use of Ibogaine and 5-MeO-DMT, as multi-modal method for treatment recovery.

This study was conducted to examine the intensity of mystical experiences following administration of 5-MeO-DMT (in the form of vaporized bufotoxin) to 20 participants in a residential psycho-spiritual retreat in Mexico. The study also focused on comparing the intensity of mystical experiences occasioned by 5-MeO-DMT with that recorded in a prior laboratory-based psilocybin study: Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study

This article is about a study on how withdrawal symptoms and cravings change with the use of ibogaine. The study showed the decrease of opioid withdrawals and drug cravings in 50 participants with opioid use disorder (OUD) that underwent a week-long detoxification treatment protocol with ibogaine. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine

This study examined the persisting effects, self-perceived challenges, and potential benefits associated with positive outcomes following ibogaine detoxification using data collected as part of a larger online retrospective study of 73 patients who received treatment for chronic opioid use at Crossroads Treatment Center in Mexico between 2012 and 2015. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification